BACKGROUND: Explore the use of electronic health records (EHRs) in fetal alcohol syndrome (FAS) surveillance systems. METHODS: Using EHRs we identified diagnoses and anthropometric measurements related to the FAS criteria developed by the Fetal Alcohol Syndrome Surveillance Network (FASSNet) among children aged 0 to 12 years. RESULTS: There were 143,393 distinct children aged between 0 and 12 years enrolled in Kaiser Permanente, Georgia, during the study period. Based on diagnoses and anthropometric measurements, 20,101 children met at least one criterion of interest, and when grouped into combinations of different criteria there were 2285 who met GROWTH+CNS criteria, 76 children who met GROWTH+FACE criteria, 107 children who met CNS+FACE criteria, and 93 children who met GROWTH+CNS+FACE criteria. The prevalence of FAS as defined by FASSNet is 1.92 per 1000 children. We linked 17,084 (85.0%) children to their mothers in the health plan; only 3% of mothers of children in the GROWTH+CNS+FACE group had an indication of alcohol or drugs use, but they had the highest rate of depression (39%). CONCLUSION: Data of utility in identification of FAS are readily available in EHRs and may serve as a basis for intervention with at-risk children and in planning of future FAS surveillance programs.
BACKGROUND: Explore the use of electronic health records (EHRs) in fetal alcohol syndrome (FAS) surveillance systems. METHODS: Using EHRs we identified diagnoses and anthropometric measurements related to the FAS criteria developed by the Fetal Alcohol Syndrome Surveillance Network (FASSNet) among children aged 0 to 12 years. RESULTS: There were 143,393 distinct children aged between 0 and 12 years enrolled in Kaiser Permanente, Georgia, during the study period. Based on diagnoses and anthropometric measurements, 20,101 children met at least one criterion of interest, and when grouped into combinations of different criteria there were 2285 who met GROWTH+CNS criteria, 76 children who met GROWTH+FACE criteria, 107 children who met CNS+FACE criteria, and 93 children who met GROWTH+CNS+FACE criteria. The prevalence of FAS as defined by FASSNet is 1.92 per 1000 children. We linked 17,084 (85.0%) children to their mothers in the health plan; only 3% of mothers of children in the GROWTH+CNS+FACE group had an indication of alcohol or drugs use, but they had the highest rate of depression (39%). CONCLUSION: Data of utility in identification of FAS are readily available in EHRs and may serve as a basis for intervention with at-risk children and in planning of future FAS surveillance programs.
Authors: Maria C S Inacio; Elizabeth W Paxton; Yuexin Chen; Jessica Harris; Enid Eck; Sue Barnes; Robert S Namba; Christopher F Ake Journal: Infect Control Hosp Epidemiol Date: 2011-04 Impact factor: 3.254
Authors: Stewart B Harris; Richard H Glazier; Jordan W Tompkins; Andrew S Wilton; Vijaya Chevendra; Moira A Stewart; Amardeep Thind Journal: BMC Health Serv Res Date: 2010-12-23 Impact factor: 2.655
Authors: Anna T Bukowinski; Margaret A K Ryan; Donald J Slymen; Carter J Sevick; John E Alcaraz; Tyler C Smith Journal: Paediatr Perinat Epidemiol Date: 2008-11 Impact factor: 3.980
Authors: Anita W M Suijkerbuijk; Ingrid V F van den Broek; Henk J Brouwer; Ann M Vanrolleghem; Johanna H K Joosten; Robert A Verheij; Marianne A B van der Sande; Mirjam E E Kretzschmar Journal: BMC Fam Pract Date: 2011-07-08 Impact factor: 2.497
Authors: Michael Klompas; Gillian Haney; Daniel Church; Ross Lazarus; Xuanlin Hou; Richard Platt Journal: PLoS One Date: 2008-07-09 Impact factor: 3.240
Authors: Leslie A O'Leary; Linnette Ortiz; April Montgomery; Deborah J Fox; Christopher Cunniff; Margaret Ruttenber; April Breen; Sydney Pettygrove; Don Klumb; Charlotte Druschel; Jaime L Frías; Luther K Robinson; Jacquelyn Bertrand; Kelly Ferrara; Maureen Kelly; Suzanne M Gilboa; F John Meaney Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-03-12